<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>CUTIS LAXA INTERNATIONALE</provider_name><provider_url>https://www.cutislaxa.org/fr/</provider_url><title>Nouvelles mutations  (ATP6V1E1, ATP6V1A) - CUTIS LAXA INTERNATIONALE</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="QXmttfRp3f"&gt;&lt;a href="https://www.cutislaxa.org/fr/new-mutations-atp6v1e1-atp6v1a/"&gt;Nouvelles mutations   &lt;u&gt;(ATP6V1E1, ATP6V1A)&lt;/u&gt;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.cutislaxa.org/fr/new-mutations-atp6v1e1-atp6v1a/embed/#?secret=QXmttfRp3f" width="600" height="338" title="&#xAB;&#xA0;Nouvelles mutations   &lt;u&gt;(ATP6V1E1, ATP6V1A)&lt;/u&gt;&#xA0;&#xBB; &#x2014; CUTIS LAXA INTERNATIONALE" data-secret="QXmttfRp3f" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://www.cutislaxa.org/wp-content/uploads/2017/07/gene-small.jpg</thumbnail_url><thumbnail_width>300</thumbnail_width><thumbnail_height>169</thumbnail_height><description>ATP6V1E1 ou ATP6V1A, sont les nouvelles mutations publi&#xE9;es par une &#xE9;quipe de chercheurs incluant, entre autres, Mmes Gardeitchik, Mohammed, De Paepe, Malfait et Morava ainsi que Mrs Kornak, Wevers et Callewaert, chercheurs avec qui nous sommes en lien. Ces mutations peuvent &#xEA;tre incluses dans la Cutis Laxa Autosomale R&#xE9;cessive type 2 (ARCL2). Elles entrainent des [&hellip;]</description></oembed>
